Project Stories help illustrate how Teijin Pharma takes a unique
approach to developing new treatments.
Patient-friendly medical devices are environment-friendly medical devices
Home Healthcare Business
We have continued to develop, manufacture, and sell "oxygen concentrators" while putting patients first.Before knowing it, this service has evolved into a “circular economy” service that is both environmentally friendly and achieves economic growth.
Thorough Quality and Safety Management
Regulatory Compliance is a Vital Part of Teijin Pharma
Pharmaceutical Business
Ensuring that medical products comply with stringent laws and regulations is a long process. Nevertheless, having the right procedures and people in place to effectively manage risk helps Teijin Pharma to go on looking after patients’ safety after our products go on sale.
Reaching Out into a New Area of Healthcare
Innovative Rehabilitation Devices for Stroke Patients
Rehabilitation Field
The central nervous system coordinates and influences all of our movements, sending and receiving information on everything we experience around us. Damage to the system due to injury or disease can lead to loss of mobility and is the world’s leading cause of disability.
Building a Healthcare Framework to Support the Elderly
Enabling First Class Care at Home
Home Healthcare Business
As the global population ages, the way that we provide healthcare for the elderly must adapt. Teijin Pharma is dedicated to finding solutions that offer optimum care for patients at home, so they can continue to enjoy good quality of life, no matter what age.
The 100th Anniversary of the Teijin Group
Celebrating Teijin Pharma’s History as a Core Part of Teijin
Special Edition
June 17, 2018 marked 100 years since the founding of Teijin. With healthcare as a core pillar of the Teijin Group’s operation, Teijin Pharma have played a key role so far in the history of Teijin. Read on to find out more.
Building New Alliances and Realizing the Potential of Our Network
Expanding the Range of Treatments Available to Patients of Acromegaly
Pharmaceutical Business / Cardiovascular and Metabolic Diseases
Teijin Pharma realizes the importance of choice for patients. When it comes to treatments, patients benefit from a range of options to suit their personal circumstances. In the case of Acromegaly, Teijin Pharma saw how they could improve patients’ quality of life through Somatuline subcutaneous injection.
The History of Our Home Oxygen Therapy
Enriching the Lives of Patients
through Our Community
Home Healthcare Business / Respiratory Diseases
Home Oxygen Therapy (HOT) was a major part of the forming chapter of the Teijin Pharma story, as explored in Project Story Vol. 6. But the development of Teijin’s first membrane-type oxygen concentrator and its subsequent release in 1982 is only half the story. Teijin’s HOT technology has gone on growing and evolving alongside the business that supports it.
The History of Our Home Oxygen Therapy
Building a new culture of healthcare
through innovation
Home Healthcare Business / Respiratory Diseases
Dedicated to pioneering medical solutions, Teijin Pharma began business with the
same commitment to taking on new challenges which they have to this day. The
ability to recognize the needs of the healthcare industry and commit to the right
solutions has defined the company from day one.
How Teijin Pharma Is Changing the Future of Pharmaceutical Manufacturing
Creating Products to Match Medical Needs
Pharmaceutical Business / Respiratory Diseases
In line with their philosophy to Enhance Quality of Life, Teijin Pharma has launched a new 45 mg reduced-size tablet form of their proprietary expectorant drug. Read on to find out how this small modification will greatly change the way patients of respiratory diseases are treated.
SLEEPMATE® Is a Medical Device Designed to Help People Suffering from SAS – Improving Quality of Life for SAS Patients
Home Healthcare Business /
Respiratory Diseases
Sleep Apnea Syndrome (SAS) is a modern disorder that is estimated to affect more than 3 million people in Japan. Learn how Teijin utilized its home healthcare business expertise and insights to develop SLEEPMATE, an innovative device that treats SAS.
Utilizing Teijin Group Synergies to Provide a Wide Range of Treatments
Building a Strong Platform in the Field of Bone and Joint Diseases
Pharmaceutical Business /
Bone and Joint Diseases
Teijin Pharma are always looking ahead. Since they first foresaw the importance of treating osteoporosis in the 1980s, Teijin Pharma have challenged development of everything from simple diagnostic tools to a wide range of treatments in the field of bone and joint diseases.
Teijin Pharma’s Response to the Great East Japan Earthquake – Providing Home Healthcare Support in a Disaster
Home Healthcare Business / Respiratory Diseases
From the moment the earthquake struck, Teijin Pharma members moved swiftly and diligently to supply oxygen cylinders to affected patients.
A New Drug Born from R&D
Pharmaceutical Business / Cardiovascular and Metabolic Diseases
Teijin Pharma has three target categories within the world of healthcare, bone and joint diseases, respiratory diseases and cardiovascular and metabolic diseases. This is the story of a new drug which helped us to grow in the cardiovascular and metabolic diseases’ field, improving quality of life for patients.